Trump Signs Executive Order Creating NIH Women's Health Division, Backed by First Lady
President Trump signed an executive order creating a new NIH Women's Health Division and a White House Women's Health Task Force led by Susie Wiles and RFK Jr., in a Rose Garden ceremony with First Lady Melania Trump. The order sets out five research pillars weeks before the 2026 midterms, drawing criticism from some health groups.
President Donald Trump on Monday, Oct. 19, 2026, signed an executive order titled "Advancing Women's Health to Improve Outcomes in All Phases of Life," creating a new Women's Health Division within the National Institutes of Health and a dedicated White House Women's Health Task Force, in a Rose Garden ceremony alongside First Lady Melania Trump, according to Florida's Voice. White House Chief of Staff Susie Wiles and Health Secretary Robert F. Kennedy Jr. will lead the new task force, and administration officials confirmed it held its inaugural working session immediately after the 11 a.m. signing ceremony. The Associated Press, carried by the Hastings Tribune, reported the order is aimed at boosting women's health research under a plan backed by the first lady, who framed the initiative as "a generational shift in federal healthcare priorities."

What happened
The executive order sets out what the White House calls the "First Lady's Five Pillars of Women's Health Innovation." According to Florida's Voice, the five pillars are: directing research funding toward diseases uniquely affecting women; using artificial intelligence and advanced technology to accelerate discoveries; expediting translation of laboratory research into clinical treatments while maintaining federal safety standards; keeping breakthroughs accessible and affordable across income levels; and fostering open dialogue to eliminate social taboos around women's health.
The new NIH division targets maternal health, mental health and endometriosis as research priorities, while also addressing Alzheimer's disease, osteoporosis, heart disease and stroke, with a stated focus on translating research into treatments and cures. No dollar figure was attached to the order in either outlet's reporting, and funding levels have not yet been specified.
This is the second executive order spearheaded by Melania Trump, following her 2025 "Fostering and Future" program. In planned remarks at the ceremony, the first lady was to highlight the role of artificial intelligence in speeding health discoveries and easing social taboos. "Previous generations fought for women's rights. Our generation will fight to discover the cures that will ensure a woman can live her life in health and to the fullest," she said, per Florida's Voice.
Why it matters
The order creates new federal research infrastructure dedicated to conditions that disproportionately or uniquely affect women, an area that patient advocates and researchers have long argued is underfunded relative to disease burden. The institutional footprint is concrete: one new NIH division and one White House task force, chaired through an unusual pairing of the chief of staff's office and the Health Department.
The timing carries political weight. The signing comes weeks before the November 2026 midterm elections, and some health groups criticized the move as politically motivated, according to the AP's reporting. Those critics noted the administration had previously urged cuts at the Health Department, including at NIH, raising questions about policy consistency between earlier budget positions and the new research push. The administration's position, as reflected in the order's stated pillars, is that the initiative directs money toward women-specific conditions and accelerates the path from laboratory to clinic without lowering federal safety standards.
For Florida readers, the story lands amid heavy midterm coverage in the state. The NIH research priorities named in the order, particularly maternal health and endometriosis, intersect with Florida's large population and ongoing state health-policy debates, giving the federal action a local dimension even though the order itself is national in scope.
How it is being covered
Ground.news counts 61 sources carrying the story, with a left/centre/right split of 20/45/35 percent, and factuality ratings of high or very high for 39 of 52 rated outlets. The distribution leans center and right, consistent with the story's prominence on Florida's Voice and its framing around a first lady-led initiative. No blindspot was flagged in the aggregation data, meaning no major partisan bloc is entirely absent from coverage, though the criticism from health groups about timing and prior NIH budget positions appears mainly in wire-sourced reporting rather than in sympathetic outlet framing.
What to watch
Three things to watch in the coming weeks. First, whether the White House attaches dollar figures to the new NIH division and task force, since neither outlet's reporting includes funding levels and the order's practical reach depends on appropriations. Second, whether the task force led by Wiles and Kennedy Jr. publishes a work plan or timeline for the five pillars, and whether the AI-focused research agenda draws scrutiny from safety regulators or congressional committees. Third, how the initiative factors into midterm campaigning, including whether critics' arguments about the administration's earlier NIH budget positions gain traction, and whether the first lady makes further public appearances on the issue following the Rose Garden ceremony.
By the numbers
Source snapshot
